Posts filed under: Diabetes
Dexcom has announced that its G6 continuous glucose monitoring (CGM) system has won the CE Mark for use during pregnancy and will be available in the United Kingdom as soon as Spring 2020. During pregnancy, hormones that help the baby...
Medtronic has recalled the MiniMed 600 Series Insulin Pumps due to missing or broken retainer rings resulting in incorrect insulin dosages. The MiniMed Insulin Pumps are designed to administer proper doses of insulin when the user’s blood sugar levels dip....
A clinical trial, funded by the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) revealed closed-loop artificial pancreas were better at controlling patients’ blood glucose levels than existing treatments. The artificial pancreas allows for ‘closed-loop’ control which tracks...
Register to receive a free Diabetes Market Analysis, Size, and Trends Report synopsis and brochure. Back in 2017, the FDA approved Fiasp, a rapid-acting insulin, for use by IV infusion under supervision by a healthcare professional or by subcutaneous multiple...
Register to receive a free U.S. Market Report Suite for Diabetes Devices report synopsis and brochure UC Davis Health scientists and physicians have discovered a cellular connection between diabetes and blood vessel narrowing that increases risks of serious health conditions such as...
Register to receive a free U.S. Market Report Suite for Diabetes Devices report synopsis and brochure On May 21 2019, LifeScan announced a partnership with Sanvita Medical to move into the continuous glucose monitoring (CGM) market this week, which is poised...
Diabetes Monitoring Trends In the realm of diabetes monitoring, continuous glucose monitoring (CGM) allows for a more accurate reading of how blood glucose levels fluctuate throughout the day by measuring interstitial glucose levels on a continuous basis and estimating blood...
Register to receive a free US Market Report Suite for Diabetes Devices report synopsis and brochure Insulin Statistics Insulin is a hormone that causes glucose uptake from the blood through the cells of the liver, muscle, and fat tissue to be stored...
Register to receive a free US Market Report Suite for Diabetes Devices report synopsis and brochure POPS! Diabetes Care is announcing the U.S. Food and Drug Administration (FDA) clearance of their POPS!® one Blood Glucose Monitoring System. The system is designed to...
Register to receive a free Europe Market Report Suite for Diabetes Devices report synopsis and brochure Novo Nordisk announced plans to make the durable, connected insulin pens NovoPen® 6 and NovoPen Echo® Plus commercially available across key markets commencing in early 2019....
12
?
Want more information about the market report mentioned in this article?
Want more information about the market report mentioned in this article?
